ARL4C and breast cancer: Our findings revealed that the drugs corresponding to four genes exhibited the potential to specifically impact BC (ZNF165, Haijinsha, Kuxingren, and Kunbu et al.; MXRA7, Chuanlianzi, Dazao, and Gehua et al.; CEMIP, Diercao, Maoyancao, and Muxiang et al.; and ARL4C, Baixianpi, Baihe, and Beiliujinu et al.), as evidenced by the data presented in Table S1.